In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

BLS Pharmaceuticals Limited Balance Sheet Statement - Assets

As of 30 Jun 2025, The total current assets of BLS Pharmaceuticals Limited (ASX:BLS) was around $- which consisted of no Cash, no Inventory and no Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$-
Current assets
$-
Total assets
$-

The latest balance sheet of BLS Pharmaceuticals Limited also showed no Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $-.

BLS Pharmaceuticals Limited Balance Sheet Statement - Liabilities

BLS's latest annual results shows the balance sheet has no Accounts Payable. Also there were no Short/Long term debt, no Long term debt, no Other Current liabilities and no Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$-
Current liabilities
$-
Total liabilities
$-

As per the 30 Jun 2025's annual report of BLS Pharmaceuticals Limited, the total liabilities were $-.

BLS Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of BLS Pharmaceuticals Limited showed the total stock holder equity was $- which consisted of no Common stocks, no Retained earnings and no Other stock holder equity.

BLS Balance Sheet Statement History

Following table shows the history of balance sheet for BLS Pharmaceuticals Limited (BLS).

30 Jun 2025 30 Jun 2024 30 Jun 2023 30 Jun 2022
Cash - 1,027,989 3,845,969 2,168,009
Net Receivables - 1,110,821 897,971 17,848
Inventory - 2,141,923 994,806 310,230
Total Current Assets - 5,585,085 6,040,089 2,817,943
Property Plant Equipment - 824,073 85,024 74,649
Good Will - 288,476 11,568,010 -
Intangible Assets - - - 30,269
Other Assets - - - -
Deferred Long Term Asset Charges - - - -
Total Assets - 6,697,634 17,693,123 2,922,861
Accounts Payable - 1,192,864 1,205,254 95,102
Short/Long Term Debt - 673,723 - -
Other Current Liabilities - - - -
Long Term Debt - - - -
Other Liabilities - - - -
Total Current Liabilities - 2,907,351 2,686,988 981,510
Total Liabilities - 3,398,078 2,686,988 981,510
Common Stock - 18,997,751 17,547,751 62,177,536
Retained Earnings - -15,595,471 -2,483,750 -60,477,334
Treasury Stock - - - -
Other Stockholder Equity - - - -
Total Stockholder Equity - 3,606,224 15,137,130 1,888,490
Net Tangible Assets - 3,317,748 3,569,120 1,858,221

BLS Pharmaceuticals Limited (ASX:BLS) Balance Sheet Statement FAQ

1. How much Cash BLS Pharmaceuticals Limited has on their balance sheet?

As of 30 Jun 2025, BLS Pharmaceuticals Limited (ASX:BLS) has no Cash.

2. What's the long term debt of BLS Pharmaceuticals Limited?

As per the latest Balance sheet of BLS Pharmaceuticals Limited (ASX:BLS), it has no Long term debt.

3. How much share holder equity does BLS Pharmaceuticals Limited has?

The BLS Pharmaceuticals Limited (ASX:BLS)'s balance sheet shows that it has no Total stock holder equity.